172 related articles for article (PubMed ID: 20355224)
21. Popular ergogenic drugs and supplements in young athletes.
Calfee R; Fadale P
Pediatrics; 2006 Mar; 117(3):e577-89. PubMed ID: 16510635
[TBL] [Abstract][Full Text] [Related]
22. Anabolic steroids: implications for the nurse practitioner.
Duncan DJ; Shaw EB
Nurse Pract; 1985 Dec; 10(12):8, 13-5. PubMed ID: 4080279
[TBL] [Abstract][Full Text] [Related]
23. Anabolic steroids in athletics.
Holden SC; Calvo RD; Sterling JC
Tex Med; 1990 Mar; 86(3):32-6. PubMed ID: 2333633
[TBL] [Abstract][Full Text] [Related]
24. Anabolic-androgenic steroids and adolescents: recent developments.
Denham BE
J Addict Nurs; 2012 Oct; 23(3):167-71, quuiz 172-3. PubMed ID: 24335733
[TBL] [Abstract][Full Text] [Related]
25. Sports medicine: performance-enhancing drugs.
Gregory AJ; Fitch RW
Pediatr Clin North Am; 2007 Aug; 54(4):797-806, xii. PubMed ID: 17723878
[TBL] [Abstract][Full Text] [Related]
26. Linear keloids resulting from abuse of anabolic androgenic steroid drugs.
Scott MJ; Scott MJ; Scott AM
Cutis; 1994 Jan; 53(1):41-3. PubMed ID: 8119077
[TBL] [Abstract][Full Text] [Related]
27. Anabolic steroids and ergogenic aids.
Hough DO
Am Fam Physician; 1990 Apr; 41(4):1157-64. PubMed ID: 2181832
[TBL] [Abstract][Full Text] [Related]
28. [Anabolic steroids and sports].
Kopera H
Wien Med Wochenschr; 1986 Sep; 136(18):453-6. PubMed ID: 3798929
[TBL] [Abstract][Full Text] [Related]
29. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.
Curry LA; Wagman DF
Percept Mot Skills; 1999 Feb; 88(1):224-33. PubMed ID: 10214647
[TBL] [Abstract][Full Text] [Related]
30. Adverse effects of anabolic steroids in athletes. A constant threat.
Maravelias C; Dona A; Stefanidou M; Spiliopoulou C
Toxicol Lett; 2005 Sep; 158(3):167-75. PubMed ID: 16005168
[TBL] [Abstract][Full Text] [Related]
31. Anabolic steroids: a review of the literature.
Haupt HA; Rovere GD
Am J Sports Med; 1984; 12(6):469-84. PubMed ID: 6391216
[TBL] [Abstract][Full Text] [Related]
32. [Anabolic androgenic steroids: a nightmare for control of doping or a drug?].
Stárka L
Cas Lek Cesk; 1996 Mar; 135(5):131-4. PubMed ID: 8681352
[TBL] [Abstract][Full Text] [Related]
33. Can anabolic steroids or human growth hormone affect the growth and maturation of adolescent athletes?
Rogol AD
Pediatr Exerc Sci; 2014 Nov; 26(4):423-7. PubMed ID: 25372376
[No Abstract] [Full Text] [Related]
34. Stay alert for performance-enhancing substance use.
Jarvi JF
JAAPA; 2004 Dec; 17(12):36-9. PubMed ID: 15631019
[No Abstract] [Full Text] [Related]
35. A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health.
Lindqvist AS; Moberg T; Eriksson BO; Ehrnborg C; Rosén T; Fahlke C
Br J Sports Med; 2013 Oct; 47(15):965-9. PubMed ID: 23613517
[TBL] [Abstract][Full Text] [Related]
36. Anesthesia for athletes using performance-enhancing drugs.
Joyce JA
AANA J; 1991 Apr; 59(2):139-44. PubMed ID: 2035296
[TBL] [Abstract][Full Text] [Related]
37. High school athletes and the use of ergogenic aid.
Krowchuk DP; Anglin TM; Goodfellow DB; Stancin T; Williams P; Zimet GD
Am J Dis Child; 1989 Apr; 143(4):486-9. PubMed ID: 2929532
[TBL] [Abstract][Full Text] [Related]
38. Meat products as potential doping traps?
Braun H; Geyer H; Koehler K
Int J Sport Nutr Exerc Metab; 2008 Oct; 18(5):539-42. PubMed ID: 19051433
[No Abstract] [Full Text] [Related]
39. Sudden anabolic steroid abuse-related death in athletes.
Di Paolo M; Agozzino M; Toni C; Luciani AB; Molendini L; Scaglione M; Inzani F; Pasotti M; Buzzi F; Arbustini E
Int J Cardiol; 2007 Jan; 114(1):114-7. PubMed ID: 16364470
[No Abstract] [Full Text] [Related]
40. Cardiomyopathy induced by performance enhancing drugs in a competitive bodybuilder.
Mark PB; Watkins S; Dargie HJ
Heart; 2005 Jul; 91(7):888. PubMed ID: 15958355
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
